InsiderTrades

Form 4 for CYH COMMUNITY HEALTH SYSTEMS INC

Accepted 2026-03-03 00:00:00 ET · period of report 2026-03-01 · accession 0001193125-26-088507 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-03-03 2026-03-01 CYH Pitt Justin D Pres, Chief Legal, Admin Off M - OptEx $0.00 +30.0K 272.7K +12% $0
D 2026-03-03 2026-03-01 CYH Pitt Justin D Pres, Chief Legal, Admin Off A - Grant $0.00 +40.0K 312.7K +15% $0
D 2026-03-03 2026-03-01 CYH Pitt Justin D Pres, Chief Legal, Admin Off F - Tax $3.46 -24.9K 287.8K -8% -$86.2K
D 2026-03-03 2026-03-01 CYH Pitt Justin D Pres, Chief Legal, Admin Off M - OptEx $0.00 -30.0K 0 -100% $0
DM 2026-03-03 2026-03-01 CYH Pitt Justin D Pres, Chief Legal, Admin Off A - Grant $0.00 +120.0K 40.0K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-03-01 M A 30,000 $0.00 272,672 D — — (F1) The vesting of these performance-based restricted shares was based on the Issuer's attainment of certain performance objectives between 1/1/2023 and 12/31/2025 (the "2023-2025 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2023-2025 Performance Period, the award vested on 3/1/2026 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2023.
2 Common Common Stock 2026-03-01 A A 40,000 $0.00 312,672 D — — (F2) The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant.
3 Common Common Stock 2026-03-01 F D 24,922 $3.46 287,750 D — —
4 Derivative Performance Based Restricted 2026-03-01 M D 30,000 $0.00 0 D $0.00 · — to — 30,000 Common Stock (F1) The vesting of these performance-based restricted shares was based on the Issuer's attainment of certain performance objectives between 1/1/2023 and 12/31/2025 (the "2023-2025 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2023-2025 Performance Period, the award vested on 3/1/2026 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2023.
5 Derivative Performance Based Restricted 2026-03-01 A A 80,000 $0.00 80,000 D $0.00 · — to — 80,000 Common Stock (F3) The vesting of these performance-based restricted shares is allocated to the Issuer's attainment of the following predetermined performance objectives between 1/1/2026 and 12/31/2028 (the "2026-2028 Performance Period"), as follows: 50% to a Cumulative Same-Store Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2026-2028 Performance Period.
6 Derivative Stock Options (Right to Buy) 2026-03-01 A A 40,000 $0.00 40,000 D $3.46 · 2027-03-01 to 2036-02-29 40,000 Common Stock (F4) Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant.